• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Tetranectin (CLEC3B)

ACP22229

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP22229 Target NameCLEC3B
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range22-202Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP05452
Background Information
  • Uniprot Id

    P05452

  • Target Species

    Human

  • Target Name

    CLEC3B

  • Target Full Name

    Tetranectin

  • Target Function

    Tetranectin binds to plasminogen and to isolated kringle 4. May be involved in the packaging of molecules destined for exocytosis.

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Found in plasma.

  • Target Research Area

    Cardiovascular

  • Target Synonyms

    C type lectin domain family 3 member B; C-type lectin domain family 3 member B; Clec3b; Plasminogen kringle 4 binding protein; Plasminogen kringle 4-binding protein; TETN_HUMAN; Tetranectin (plasminogen binding protein); Tetranectin; TN; TNA

  • Target Background

    Enables calcium ion binding activity; heparin binding activity; and kringle domain binding activity. Involved in bone mineralization and cellular response to transforming growth factor beta stimulus. Located in cytoplasm; extracellular space; and granular component. Part of collagen-containing extracellular matrix. Implicated in osteoarthritis.

Inquire Recombinant Human Tetranectin (CLEC3B) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification